Literature DB >> 17507546

Nontuberculous mycobacterial sensitization in the United States: national trends over three decades.

Kamran Khan1, Jun Wang, Theodore K Marras.   

Abstract

RATIONALE: The prevalence of pulmonary nontuberculous mycobacterial (NTM) infections in the United States appears to be rising, but it is unclear if this is due to enhanced detection or actual increases in the burden of infection. Temporal changes in the epidemiology of Mycobacterium intracellulare sensitization may help explain recently observed trends in pulmonary NTM infections.
OBJECTIVES: Describe the epidemiology of M. intracellulare sensitization in the United States in 1971-1972 and 1999-2000.
METHODS: We studied nationally representative cohorts of the United States' noninstitutionalized civilian population participating in the 1971-1972 and 1999-2000 National Health and Nutrition Examination Surveys (NHANES). Participants were skin tested with M. intracellulare antigen and sensitization prevalence was compared across NHANES surveys and between participant subgroups. Logistic regression was used to identify associations between participant characteristics, environmental factors, and NTM sensitization.
MEASUREMENTS AND MAIN RESULTS: The 1971-1972 and 1999-2000 NHANES cohorts included 1,490 and 7,384 individuals, respectively. Between 1971-1972 and 1999-2000, the prevalence of M. intracellulare sensitization increased from 11.2% (95% confidence interval, 9.2-13.5%) to 16.6% (95% confidence interval, 13.2-20.6%). On multivariate analysis of the 1999-2000 cohort, age, sex, race, birthplace, education, and occupation were strongly associated with M. intracellulare sensitization.
CONCLUSIONS: In 1999-2000, an estimated one in six persons in the United States demonstrated M. intracellulare sensitization, up from one in nine persons in 1971-1972. The observed rising prevalence of sensitization is consistent with observed increases in the rates of pulmonary NTM infections in the United States.

Entities:  

Mesh:

Year:  2007        PMID: 17507546     DOI: 10.1164/rccm.200702-201OC

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  47 in total

1.  Discordance among commercially available diagnostics for latent tuberculosis infection.

Authors:  James D Mancuso; Gerald H Mazurek; David Tribble; Cara Olsen; Naomi E Aronson; Lawrence Geiter; Donald Goodwin; Lisa W Keep
Journal:  Am J Respir Crit Care Med       Date:  2011-12-08       Impact factor: 21.405

2.  Nontuberculous mycobacterial lung disease prevalence at four integrated health care delivery systems.

Authors:  D Rebecca Prevots; Pamela A Shaw; Daniel Strickland; Lisa A Jackson; Marsha A Raebel; Mary Ann Blosky; Ruben Montes de Oca; Yvonne R Shea; Amy E Seitz; Steven M Holland; Kenneth N Olivier
Journal:  Am J Respir Crit Care Med       Date:  2010-06-10       Impact factor: 21.405

3.  Natural disasters and nontuberculous mycobacteria: a recipe for increased disease?

Authors:  Jennifer R Honda; Jon N Bernhard; Edward D Chan
Journal:  Chest       Date:  2015-02       Impact factor: 9.410

Review 4.  Management of nontuberculous mycobacterial infection in the elderly.

Authors:  Mehdi Mirsaeidi; Maham Farshidpour; Golnaz Ebrahimi; Stefano Aliberti; Joseph O Falkinham
Journal:  Eur J Intern Med       Date:  2014-03-29       Impact factor: 4.487

5.  A case report of a male patient receiving treatment for anorexia nervosa and comorbid obsessive compulsive disorder who was later diagnosed with nontuberculosis Mycobacterium.

Authors:  Brad A MacNeil; Chloe C Hudson; Pallavi Nadkarni; Kathleen Dempsey
Journal:  Eat Weight Disord       Date:  2020-07-24       Impact factor: 4.652

6.  Rapid method for identification of six common species of mycobacteria based on multiplex SNP analysis.

Authors:  Hongxiu Wang; Jun Yue; Min Han; Jinghui Yang; Yanlin Zhao
Journal:  J Clin Microbiol       Date:  2009-11-04       Impact factor: 5.948

7.  Identification of nontuberculous mycobacteria using multilocous sequence analysis of 16S rRNA, hsp65, and rpoB.

Authors:  Si Hyun Kim; Jeong Hwan Shin
Journal:  J Clin Lab Anal       Date:  2017-02-23       Impact factor: 2.352

Review 8.  Nontuberculous mycobacteria infection in solid organ transplant recipients.

Authors:  C Piersimoni
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-07-07       Impact factor: 3.267

9.  Management of pulmonary nontuberculous mycobacterial disease.

Authors:  Kathleen L Horan; Shawn J Skerrett
Journal:  F1000 Med Rep       Date:  2009-12-15

10.  Hospital costs in the US for pulmonary mycobacterial diseases.

Authors:  Mehdi Mirsaeidi; Mary Beth Allen; Golnaz Ebrahimi; Dean Schraufnagel
Journal:  Int J Mycobacteriol       Date:  2015-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.